D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
3226
CALL
DELISTED
Radius Recycling
RDUS
| $278K | ﹤0.01% |
+8,300
| New | +$243K |
|
3227
Ingles Markets
IMKTA
$1.63B
| $277K | ﹤0.01% |
8,007
-29,434
| -79% | -$801K |
|
|
REV
3228
DELISTED
Revlon, Inc.
REV
| $277K | ﹤0.01% |
+12,714
| New | +$282K |
|
3229
PRA Group
PRAA
$648M
| $276K | ﹤0.01% |
+8,328
| New | +$264K |
|
3230
Intrepid Potash
IPI
$460M
| $275K | ﹤0.01% |
5,775
-7,573
| -57% | -$295K |
|
3231
PUT
iRhythm Holdings
IRTC
$3.59B
| $275K | ﹤0.01% |
+4,900
| New | +$256K |
|
3232
Costamare
CMRE
$1.9B
| $273K | ﹤0.01% |
47,374
+31,002
| +189% | +$184K |
|
3233
Hyster-Yale Materials Handling
HY
$593M
| $273K | ﹤0.01% |
+3,206
| New | +$264K |
|
3234
PDS Biotechnology
PDSB
$38.1M
| $273K | ﹤0.01% |
1,456
+170
| +13% | +$34.2K |
|
3235
PUT
Pilgrim's Pride
PPC
$6.82B
| $273K | ﹤0.01% |
+8,800
| New | +$287K |
|
|
RAD
3236
DELISTED
Rite Aid Corporation
RAD
| $273K | ﹤0.01% |
6,937
-801
| -10% | -$28.6K |
|
|
MDCO
3237
CALL
DELISTED
Medicines Co
MDCO
| $273K | ﹤0.01% |
10,000
| – | – |
|
3238
CALL
AGCO
AGCO
$8.78B
| $271K | ﹤0.01% |
3,800
| – | – |
|
|
USCR
3239
DELISTED
U S Concrete, Inc.
USCR
| $271K | ﹤0.01% |
3,240
-3,789
| -54% | -$298K |
|
3240
CALL
Wheaton Precious Metals
WPM
$50.6B
| $270K | ﹤0.01% |
12,200
-2,400
| -16% | -$50K |
|
3241
CALL
Curtiss-Wright
CW
$27.7B
| $268K | ﹤0.01% |
+2,200
| New | +$260K |
|
3242
CALL
Fabrinet
FN
$17.1B
| $267K | ﹤0.01% |
+9,300
| New | +$308K |
|
3243
Ocular Therapeutix
OCUL
$1.86B
| $267K | ﹤0.01% |
60,057
+2,911
| +5% | +$14.9K |
|
|
EGRX
3244
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $267K | ﹤0.01% |
+5,000
| New | +$278K |
|
|
KEM
3245
PUT
DELISTED
KEMET Corporation
KEM
| $267K | ﹤0.01% |
17,700
-47,300
| -73% | -$901K |
|
3246
CALL
HF Sinclair
DINO
$15.9B
| $266K | ﹤0.01% |
+5,200
| New | +$220K |
|
3247
CALL
Lands' End
LE
$361M
| $266K | ﹤0.01% |
13,600
| – | – |
|
|
ENTL
3248
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $266K | ﹤0.01% |
10,909
-2,288
| -17% | -$44K |
|
3249
Alaunos Therapeutics
TCRT
$4.74M
| $264K | ﹤0.01% |
425
-531
| -56% | -$382K |
|
3250
Diageo
DEO
$46.2B
| $263K | ﹤0.01% |
+1,800
| New | +$248K |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.